DTx Alliance
Also: FDA COVID-19 policy allows for remote use, digital modifications to ophthalmic devices; 23andMe launches genetics study to understand varying COVID-19 responses.
Also: Bardy Diagnostics names Ed Vertatschisch as next COO; Sapphire Digital names Kyle Raffaniello as permanent CEO.
Digital therapeutic stakeholders came together at this week's DTx East conference to discuss the state of digital health investment, developing successful business models, the need for robust data and more.